Intelligencia AI uses artificial intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster.
Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers combines and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning predictions to enable critical decision-making.
We currently work with several of the largest global pharmaceutical companies as well as mid-size and smaller biotechnology companies.
Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
Company Details
- Employees
- 120
- Founded
- -
- Address
- 180 Varick Street,
- Phone
- +1.212.653.8329
- of****@****ncia.ai
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- intelligencia.ai
- Keywords
- Artificial Intelligence, Data Science, Machine Learning, Data Visualization, Experience Design, Healthcare, Pharmaceuticals, Biotechnology, Drug Development, Clinical Trials.
- HQ
- New York, New York
Intelligencia Ai Questions
Intelligencia Ai's helpline number is +1.212.653.8329
Intelligencia Ai's website is intelligencia.ai
Intelligencia Ai's LinkedIn profile is https://www.linkedin.com/company/intelligencia-ai
Intelligencia Ai has
120 employees.
View email and phone details for 120
employees at Intelligencia Ai.
Intelligencia Ai's industry is
Software Development
Intelligencia Ai's top competitors are
Demo Pharmaceuticals S.a.,
Deeplab,
Iqvia,
Intelligencia,
Causaly,
Saphetor,
Epikast,
Deepcure,
Kos Biotechnology Partners,
Intelegencia.
Intelligencia Ai's support email address is office@intelligencia.ai
Intelligencia Ai's categories are Software Development
Intelligencia Ai's founding year is 2017
